DRD5P2: A Drug Target / Disease Biomarker (G1818)

Target Name: DRD5P2

NCBI ID: G1818

DRD5P2

Other Name(s): Dopamine receptor D5 pseudogene 2 | dopamine receptor D5 pseudogene 2

DRD5P2: A Drug Target / Disease Biomarker

DRD5P2, also known as GPRD7, is a protein that is expressed in various tissues throughout the body. It is a member of the G-protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play a crucial role in cellular signaling. DRD5P2 is highly expressed in the brain and is involved in a wide range of physiological processes, including pain perception, anxiety, and mood regulation.

One of the key functions of DRD5P2 is its role in pain perception. DRD5P2 is known to play a key role in the transmission of pain signals from the body to the brain. When the body experiences pain, DRD5P2 is released from the endocannabinoid system, which is a complex system that regulates the release of compounds that contribute to pain, anxiety, and other symptoms.

DRD5P2 is also involved in the regulation of anxiety and mood. It is known to play a role in the regulation of anxiety disorders, including in the treatment of generalized anxiety disorder (GAD) and social anxiety disorder (SAD). Studies have shown that DRD5P2 levels are decreased in individuals with GAD and SAD, and that inhibition of DRD5P2 has been shown to be effective in treating these disorders.

DRD5P2 is also involved in the regulation of sleep. It is known to play a role in the regulation of sleep-wake cycles and has been shown to be involved in the development of insomnia. Additionally, DRD5P2 is involved in the regulation of appetite and metabolism. It is known to play a role in the regulation of body weight and is also involved in the regulation of metabolism.

In addition to its role in pain perception, anxiety, and sleep, DRD5P2 is also involved in the regulation of many other physiological processes. It is involved in the regulation of inflammation, immune response, and neurodegeneration. Additionally, DRD5P2 is involved in the regulation of neurotransmitter release, including the release of dopamine and serotonin.

DRD5P2 is a potential drug target (or biomarker) due to its involvement in a wide range of physiological processes. Its role in pain perception, anxiety, and sleep, as well as its involvement in the regulation of other physiological processes, make it an attractive target for drug development. Additionally, its high expression in various tissues, including the brain, makes it a promising biomarker for a range of psychiatric and neurological disorders.

In conclusion, DRD5P2 is a protein that is involved in a wide range of physiological processes and is a potential drug target (or biomarker) due to its role in pain perception, anxiety, and sleep. Its high expression in various tissues, including the brain, makes it a promising target for drug development and its involvement in the regulation of many other physiological processes makes it an attractive candidate for further research. Further studies are needed to fully understand the role of DRD5P2 in pain perception, anxiety, and sleep, as well as its potential as a drug target.

Protein Name: Dopamine Receptor D5 Pseudogene 2

The "DRD5P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DRD5P2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets